- Report
- October 2024
- 190 Pages
Global
From €3360EUR$3,545USD£2,807GBP
€3733EUR$3,939USD£3,119GBP
- Report
- February 2025
- 200 Pages
Global
From €4256EUR$4,490USD£3,555GBP
- Report
- November 2022
- 310 Pages
Global
From €3384EUR$3,570USD£2,827GBP
The steroid injections market is a subset of the broader infusions and injectables sector, focusing on products that deliver steroids directly into the body tissues, including joints, muscles, and the spine. Steroids, which are synthetic drugs that closely resemble cortisol, a hormone that the body produces naturally, are used to reduce inflammation and suppress the immune system. They are commonly prescribed for a range of conditions including arthritis, back pain, and various inflammatory diseases. The market comprises a variety of steroid types, including cortisone, methylprednisolone, and triamcinolone, among others. These injections are often administered in outpatient settings like clinics and hospitals by healthcare professionals, including doctors and nurses, who are skilled in performing these procedures. The sector is influenced by factors such as the prevalence of chronic diseases, advancements in drug formulations, and improvements in administration techniques, providing patients with pain management and symptomatic relief options.
Some notable players in the steroid injections market include Pfizer Inc., Novartis AG, Merck & Co., Inc., Johnson & Johnson, and Bristol-Myers Squibb Company. These companies are engaged in the production and distribution of steroid injectables and continuously invest in research and development to improve the efficacy and safety profiles of their products. Show Less Read more